We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Selexis SA and Fusion Antibodies Services Form Partnership

News   May 23, 2012

 
Selexis SA and Fusion Antibodies Services Form Partnership
 
 
Advertisement
 

RELATED ARTICLES

Washington University COVID-19 Virus Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

New Treatment Regimens Show Early Efficacy Against Drug-Resistant TB

News

New treatment regimens for multidrug-resistant tuberculosis have shown early effectiveness in 85% of patients in a cohort that included many with serious comorbidities.

READ MORE

Lowering the Levels of Key Protein Might Be a Novel Way To Treat MS

News

In an animal model of multiple sclerosis, decreasing the amount of a protein made in the liver significantly protected against the development of key symptoms and promoted recovery.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE